Follow
Tumor
Tumor: is an abnormal mass of tissue that may be solid or fluid-filled. A tumor is not the same as cancer. Although, some tumors can develop into cancers. A tumor is a kind of lump or swelling and does not necessarily pose a health threat.
What's Popular in Tumor
-
DEC 19, 2025eBooksThe integration of genomic and proteomic tools improves and fosters a deeper understanding of multicancer early detectio ...DEC 18, 2025Immunology
Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been dev ...Written By: Brian G. MorrealeDEC 16, 2025Cancer
A recent article in JAMA Internal Medicine describes a common genetic mutation found in many breast cancer patients who ...Written By: Katie KokolusDEC 12, 2025Genetics & Genomics
In the 21st century, oncology has achieved extraordinary progress. We can decode a tumor’s genome, tailor therapie ...Written By: Maria PashayanDEC 11, 2025Immunology
Scientists at the Van Andel Research Institute found that reducing caloric intake can help immune cells fight cancer. Co ...Written By: Brian G. Morreale
DEC 19, 2025
eBooks
The integration of genomic and proteomic tools improves and fosters a deeper understanding of multicancer early detectio
...
DEC 18, 2025
Immunology
Immunotherapy has transformed healthcare and how physicians treat patients. Various forms of immunotherapy have been dev
...
Written By:
Brian G. Morreale
DEC 16, 2025
Cancer
A recent article in JAMA Internal Medicine describes a common genetic mutation found in many breast cancer patients who
...
Written By:
Katie Kokolus
DEC 12, 2025
Genetics & Genomics
In the 21st century, oncology has achieved extraordinary progress. We can decode a tumor’s genome, tailor therapie
...
Written By:
Maria Pashayan
DEC 11, 2025
Immunology
Scientists at the Van Andel Research Institute found that reducing caloric intake can help immune cells fight cancer. Co
...
Written By:
Brian G. Morreale
DEC 09, 2025
Cancer
We generally consider cancer a disease of aging, as the rates of almost all types of cancer increase with age. Imm
...
Written By:
Katie Kokolus
DEC 07, 2025
Cancer
The nonsteroidal anti-inflammatory (NSAID) class of drugs, often used to treat pain and fever, includes medications like
...
Written By:
Katie Kokolus
DEC 02, 2025
Cancer
Recent findings published in Scientific Reports highlight a promising target for ovarian cancer drug development, emphas
...
Written By:
Katie Kokolus
NOV 27, 2025
Immunology
Glioblastoma is a rare, aggressive, brain tumor that is difficult to treat. It originates from brain cells known as glia
...
Written By:
Brian G. Morreale
-
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...NOV 19, 2025 | 9:00 AMC.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....Speaker: Dr. Laura Keller, PharmD, PhD , Dr. Nadim Fares, MD, PhD
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
NOV 19, 2025 | 9:00 AM
C.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....
Speaker:
Dr. Laura Keller, PharmD, PhD
, Dr. Nadim Fares, MD, PhD
NOV 18, 2025 | 10:00 AM
Perineural invasion (PNI) is a well-established factor of poor prognosis in multiple cancer types, yet its mechanism remains unclear. By using a multi-omics approach, overlay of multiple spa...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
NOV 12, 2025 | 7:00 AM
In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of th...
Speaker:
Dr. Max Reichert
, Dr. Hartland Jackson
, Dr. Andrea Radtke
Sponsored By: Leica Microsystems
OCT 29, 2025 7:00 AM PT
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 28, 2025 | 7:00 AM
C.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...
Speaker:
Alison Cheung, PhD
, Colinda Scheele, PhD
, Dr. Andrea Radtke
Sponsored By: Leica Microsystems
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
-
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...NOV 19, 2025 | 7:45 AM PST
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...NOVEMBER 19, 2025 | 9:00 AM ETC.E. CREDITS
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is practiced worldwide. Taking place throughout 2025, this series wil...OCT 08, 2025 | 8:00 AM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing,...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
NOV 19, 2025
| 7:45 AM PST
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...
NOVEMBER 19, 2025 | 9:00 AM ET
C.E. CREDITS
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is practiced worldwide. Taking place throughout 2025, this series wil...
OCT 08, 2025
| 8:00 AM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing,...
OCT 08, 2025
| 8:00 AM PDT
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
SEP 10, 2025
| 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
APR 30, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...